MedTrace Logo

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

NCT07427446 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-27

No results posted yet for this study

Summary

Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups.

Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

Conditions

  • Emergence Delirium

Interventions

DRUG

Dexmedetomidine and Midazolam

Children will receive Dexamedetomedine and Midazolam

DRUG

Ketamine and Midazolam

Children will receive Ketamine and Midazolam

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Ahmed Elhaddad, Ass.prof. · Faculty of medicins,Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07427446 on ClinicalTrials.gov